Beruflich Dokumente
Kultur Dokumente
The right of Leonard A. Levin and Daniel M. Albert to be identified as authors of this work has been asserted by them in accordance with the
Copyright, Designs and Patents Act 1988.
No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including
photocopying, recording, or any information storage and retrieval system, without permission in writing from the publisher. Permissions may
be sought directly from Elsevier’s Rights Department: phone: (+1) 215 239 3804 (US) or (+44) 1865 843830 (UK); fax: (+44) 1865 853333; e-mail:
healthpermissions@elsevier.com. You may also complete your request on-line via the Elsevier website at http://www.elsevier.com/permissions.
Notice
Medical knowledge is constantly changing. Standard safety precautions must be followed, but as new research and clinical experience broaden our
knowledge, changes in treatment and drug therapy may become necessary or appropriate. Readers are advised to check the most current product
information provided by the manufacturer of each drug to be administered to verify the recommended dose, the method and duration of admin-
istration, and contraindications. It is the responsibility of the practitioner, relying on experience and knowledge of the patient, to determine dosages
and the best treatment for each individual patient. Neither the Publisher nor the author assume any liability for any injury and/or damage to
persons or property arising from this publication.
The Publisher
The
Working together to grow publisher’s
policy is to use
libraries in developing countries paper manufactured
from sustainable forests
www.elsevier.com | www.bookaid.org | www.sabre.org
Printed in China
Last digit is the print number: 9 8 7 6 5 4 3 2 1
List of Contributors
x
List of Contributors
xi
List of Contributors
Sudha K Iyengar PhD Peng Tee Khaw PhD FRCP FRCS FRCOphth Leonard A Levin MD PhD
Professor FIBiol FRCPath FMedSci Canada Research Chair of Ophthalmology
Departments of Epidemiology & Biostatistics Professor of Ocular Healing and Glaucoma and Visual Sciences
and Department of Ophthalmology and Consultant Ophthalmic Surgeon, Department of Ophthalmology
Case Western Reserve University Director of Research and Development, University of Montreal,
Cleveland, OH, USA Moorfields Eye Hospital NHS Professor, Department of Ophthalmology
Foundation Trust, and Visual Sciences
Allen T Jackson Director, National Institute for Health University of Wisconsin
Massachusetts Eye Research and Biomedical Research Centre, Madison, WI, USA
Surgery Institute Programme Director, Eyes & Vision, UCL
Harvard Medical School Partners Academic Health Science Centre Geoffrey P Lewis PhD
Cambridge, MA, USA London, UK Research Biologist, Neurobiology
Neuroscience Research Institute
L Alan Johnson MD Alice S Kim MD University of California, Santa Barbara
Private Practice Division of Ophthalmology Santa Barbara, CA, USA
Sierra Eye Associates Maimonides Medical Center
Reno, NV, USA Brooklyn, NY, USA Zhuqing Li MD PhD
Staff Scientist
Peter F Kador PhD Henry Klassen MD PhD Laboratory of Immunology
Professor Assistant Professor National Eye Institute
Departments of Ophthalmology and Department of Ophthalmology National Institutes of Health
Pharmaceutical Sciences University of California, Irvine, Bethesda, MD, USA
University of Nebraska Medical Center School of Medicine
Omaha, NE, USA Orange, CA, USA Amy Lin MD
Assistant Professor of Ophthalmology
Alon Kahana MD PhD Paul Knepper MD PhD Department of Ophthalmology
Full Member, University of Michigan Research Scientist Loyola University
Comprehensive Cancer Center, University of Illinois at Chicago Maywood, IL, USA
Attending Surgeon, C S Mott Department of Opthalmology &
Children’s Hospital, Visual Science Robert A Linsenmeier PhD
Assistant Professor Chicago, IL, USA Professor of Biomedical Engineering,
Department of Ophthalmology and Neurobiology & Physiology, and
Visual Sciences Jane F Koretz PhD Ophthalmology
Kellogg Eye Center Professor of Biophysics Biomedical Engineering Department
University of Michigan Biochemistry and Biophysics Program Northwestern University
Ann Arbor, MI, USA Rensselaer Polytechnic Institute, Evanston, IL, USA
Science Center
Randy Kardon MD PhD Troy, NY, USA Robert Listernick MD
Professor and Director of Professor of Pediatrics, Feinberg School of
Neuro-ophthalmology, Mirunalini Kumaradas MD Opth(SL) Medicine, Northwestern University,
Pomerantz Family Chair in Ophthalmology, FRCS (UK) Attending Physician
Director for Iowa City VA Center for Lecturer Division of General Academic Pediatrics
Prevention and Treatment of Vision Loss Faculty of Medicine Children’s Memorial Hospital
Department of Ophthalmology and University of Colombo Chicago, IL, USA
Visual Sciences Colombo, Sri Lanka
University of Iowa and Department of Martin Lubow MD
Veterans Affairs Jonathan H Lass MD Associate Professor of Ophthalmology
Iowa City, IA, USA The Charles I Thomas Professor and Department of Ophthalmology
Chairman The Ohio State University Eye and
Maria Cristina Kenney MD PhD Department of Ophthalmology and Ear Institute
Professor of Ophthalmology Visual Sciences Columbus, OH, USA
The Gavin Herbert Eye Institute Case Western Reserve University,
Orange, CA, USA Director, University Hospitals Eye Institute Andrew Maniotis PhD
Cleveland, OH, USA Visiting Associate Professor of
Timothy Scott Kern PhD Bioengineering
Professor of Medicine David Lederer MD Division of Science and Engineering
Department of Medicine Fellow University of Illinois at Chicago
Division of Clinical and Molecular Department of Ophthalmology Chicago, IL, USA
Endocrinology Duke University
Center for Diabetes Research Durham, NC, USA Pascale Massin MD PhD
Case Western Reserve University Professor of Ophthalmology
Cleveland, OH, USA Mark Lesk MSc MD FRCS(C) CM DABO Ophthalmology Department
Director of Vision Health Research Lariboisiere Hospital
University of Montreal Paris, France
Montreal, QC, Canada
xii
List of Contributors
Katie Matatall BS Robert Nickells BSc PhD Jonathan T Pribila MD, PhD
Department of Ophthalmology & Professor of Ophthalmology and Pediatric Ophthalmology and Adult
Visual Sciences Visual Sciences Strabismus Fellow
Washington University School of Medicine Department of Ophthalmology and Department of Ophthalmology
St Louis, MO, USA Visual Sciences University of Minnesota
University of Wisconsin Minneapolis, MN, USA
Russell L McCally PhD Madison, WI, USA
Associate Professor of Ophthalmology, Frank A Proudlock PhD
The Wilmer Eye Institute, Johns Hopkins Robert B Nussenblatt MD MPH Lecturer in Ophthalmology
Medical Institutions Department of Pathology and Ophthalmology Group
Principal Professional Staff Cancer Center University of Leicester
Applied Physics Laboratory University of Illinois Robert Kilpatrick Clinical Sciences Building
Johns Hopkins University Chicago, IL, USA Leicester Royal Infirmary
Laurel, MD, USA Leicester, UK
Joan M O’Brien MD
Stephen D McLeod MD Professor of Ophthalmology and Pediatrics Xiaoping Qi MD
Professor of Ophthalmology Comprehensive Cancer Center Associate Scientist of Ophthalmology
Department of Ophthalmology University of California San Francisco College of Medicine
University of California San Francisco San Francisco, CA, USA University of Florida
San Francisco, CA, USA Gainesville, FL, USA
Daniel T Organisciak PhD
Muhammad Memon MD Professor of Biochemistry and Narsing A Rao MD
Visiting Academic Molecular Biology, Professor of Ophthalmology and Pathology,
Department of Neuroscience Director, Petticrew Research Laboratory Keck School of Medicine, University of
Imperial College London Department of Biochemistry and Southern California,
London, UK Molecular Biology Director of Experimental Ophthalmic
Boonshoft School of Medicine Pathology and Ocular Inflammations
Joan W Miller MD Wright State University Doheny Eye Institute
The Henry Willard Williams Professor of Dayton, OH, USA Los Angeles, CA, USA
Ophthalmology and Chair, Harvard
Medical School, Michel Paques MD PhD Robert Ritch MD
Chief, Department of Ophthalmology Professor of Ophthalmology Professor of Ophthalmology, New York
Massachusetts Eye and Ear Infirmary Clinical Investigation Center Medical College, Valhalla, NY,
Boston, MA, USA XV-XX Hospital and University of Paris VI The Shelley and Steven Einhorn
Paris, France Distinguished Chair in Ophthalmology,
Austin K Mircheff PhD Chief, Glaucoma Services
Professor of Physiology & Biophysics and Heather R Pelzel BSc Surgeon Director
Professor of Ophthalmology Research Assistant New York Eye and Ear Infirmary
Department of Physiology & Biophysics Department of Ophthalmology and New York, NY, USA
Keck School of Medicine Visual Sciences
University of Southern California University of Wisconsin Joseph F Rizzo III
Los Angeles, CA, USA Madison, WI, USA Associate Professor of Ophthalmology
Massachusetts Eye and Ear Infirmary
Jay Neitz PhD Shamira Perera MBBS BSc FRCOphth Harvard Medical School
The Bishop Professor Research Fellow, Singapore Eye Boston, MA, USA
Department of Ophthalmology Research Institute,
University of Washington Consultant Michael D Roberts PhD
Seattle, WA, USA Glaucoma Service Post Doctoral Research Fellow
Singapore National Eye Centre Ocular Biomechanics Laboratory
Maureen Neitz PhD Singapore Devers Eye Institute
The Ray H Hill Professor Portland, OR, USA
Department of Ophthalmology Eric A Pierce MD PhD
University of Washington Associate Professor of Ophthalmology James T Rosenbaum MD
Seattle, WA, USA F M Kirby Center for Molecular Professor of Ophthalmology, Medicine and
Ophthalmology Cell Biology
Christine C Nelson MD FACS University of Pennsylvania School of The Edward E Rosenbaum Professor of
Professor of Ophthalmology and Surgery Medicine Inflammation Research
Kellog Eye Center Philadelphia, PA, USA Oregon Health & Science University
University of Michigan Portland, OR, USA
Ann Arbor, MI, USA Jean Pournaras MD
Research Fellow Barry Rouse PhD DSc
Service d’ophtalmologie Distinguished Professor
Hôpital Lariboisière Department of Pathobiology
Paris, France University of Tennessee
Knoxville, TN, USA
xiii
List of Contributors
Daniel R Saban PhD Genevieve Aleta Secker PhD BSc Arun N E Sundaram MBBS FRCPC
Postdoctoral Fellow in Ophthalmology Post-Doctoral Fellow Fellow, Division of Neurology and Vision
Division of Ophthalmology SA Pathology Sciences Research Program, University of
Schepens Eye Research Institute Centre for Cancer Biology Toronto,
Boston, MA, USA Department of Haematology Consultant
Adelaide, SA, Australia Neuro-ophthalmology Center
Alfredo A Sadun MD PhD University Health Network
Thornton Professor of Ophthalmology Srilakshmi M Sharma MRCP MRCOphth Toronto, ON, Canada
and Neurosurgery Uveitis Fellow
Department of Ophthalmology Bristol Eye Hospital Janet S Sunness MD
USC Keck School of Medicine University of Bristol NHS Trust Medical Director
Los Angeles, CA, USA Bristol, UK Richard E Hoover Rehabilitation Services
for Low Vision and Blindness
Abbas K Samadi PhD James A Sharpe MD FRCPC Greater Baltimore Medical Center
Assistant Professor of Surgery and Professor of Neurology, Medicine, Baltimore, MD, USA
Biochemistry Ophthalmology and Visual Sciences, and
Department of Biochemistry Otolaryngology, University of Toronto, Nathan T Tagg MD
University of Kansas Medical Center Director Neurologist and Neuro-ophthalmologist
Kansas City, KS, USA Neuro-ophthalmology Center Walter Reed Army Medical Center
University Health Network National Naval Medical Center
Pranita Sarangi BVSc&AH PhD Toronto, ON, Canada Bethesda, MD, USA
Postdoctoral Research Associate
David H Smith Center for Vaccine Biology Heather Sheardown BEng PhD Daniela Toffoli MD
and Immunology Professor Ophthalmology Resident, PGY-5
University of Rochester Medical Center Department of Chemical Engineering and Department of Ophthalmology
Rochester, NY, USA School of Biomedical Engineering Université de Montréal
McMaster University Montréal, QC, Canada
Andrew P Schachat MD Hamilton, ON, Canada
Professor of Ophthalmology, Lerner College Cynthia A Toth MD
of Medicine Alex Shortt MD PhD MRCOphth Professor of Ophthalmology and
Vice Chairman Clinical Lecturer in Ophthalmic Biomedical Engineering
Cole Eye Institute Translational Research Department of Biomedical Engineering
Cleveland Clinic Foundation Biomedical Research Centre for Duke University
Cleveland, OH, USA Ophthalmology Durham, NC, USA
Moorfields Eye Hospital
Joel E Schechter PhD London, UK Elias I Traboulsi MD
Professor of Cell and Neurobiology Professor of Ophthalmology
Keck School of Medicine Ying-Bo Shui MD PhD Cleveland Clinic Lerner College of Medicine
University of Southern California Senior Scientist Case University
Los Angeles, CA, USA Department of Ophthalmology and The Cole Eye Institute
Visual Sciences Cleveland, OH, USA
A Reagan Schiefer MD Washington University in St Louis
Trainee in Endocrinology St Louis, MO, USA James C Tsai MD
Division of Endocrinology The Robert R Young Professor and
Mayo Clinic Ian Sigal PhD Chairman
Rochester, MN, USA Research Associate Department of Ophthalmology and
Devers Eye Institute Visual Science
Ursula Schlötzer-Schrehardt ProfDr Ocular Biomechanics Laboratory Yale University School of Medicine,
Professor Portland, OR, USA Chief of Ophthalmology, Yale-New
Department of Ophthalmology Haven Hospital
University of Erlangen-Nürnberg James L Stahl PhD Yale Eye Center
Erlangen, Germany Associate Scientist New Haven, CT, USA
Department of Medicine
Ingo Schmack MD University of Wisconsin School of Medicine Budd Tucker PhD
Attending Physician and Public Health Investigator
University of Bochum Madison, WI, USA Department of Ophthalmology
Department of Ophthalmology Schepens Eye Research Institute, Harvard
Bochum, Germany Roger F Steinert MD Medical School
Professor and Chair of Ophthalmology, Boston, MA, USA
Leopold Schmetterer PhD Professor of Biomedical Engineering,
Professor Director, Gavin Herbert Eye Institute
Departments of Clinical Pharmacology and University of California Irvine
Biomedical Engineering and Physics Irvine, CA, USA
Medical University of Vienna
Vienna, Austria
xiv
List of Contributors
xv
Dedication
Translational research offers both the opportunity and the As disease gene identification rocketed ahead, attention
challenge for medical research in the decades ahead, as phy- turned to genomics and studies of the expression, cellular
sicians and clinician-scientists work to understand disease localization and biological function of the aberrant gene
by utilizing the vast storehouse of detailed biological infor- products. It is these considerations that the present book
mation that has been uncovered about the eye and visual addresses, for ultimately a true understanding of disease
system. Ultimately, the practice of medicine, and delivery of mechanisms, in many cases, lies buried within the genomic
care to ameliorate disease, advances best and most effectively biology of these diseases.
upon understanding the causative pathophysiology, as is Studying any one of these genes requires major effort to
addressed in this book. piece together an understanding of the relationship between
I am delighted to see the advances represented in the gene and disease. Consider, for example, the TIGR/MYOC
chapters of this book. While no one volume can encompass gene that encodes the protein myocillin that is expressed in
the entirety of the clinical medicine of ophthalmology, the the trabecular meshwork. Mutations in this gene result in
editors have assembled a broad and expert group of clini- early onset or even congenital dysregulation of intraocular
cian-scientists who have written thoughtfully and cogently pressure and leads to severe glaucoma in humans. Yet labo-
on many topics of modern ophthalmic disease research. ratory-created mice carrying the myocilin gene knockout
These chapters are multidisciplinary and provide a good show only a minimal phenotype. Two lessons are immedi-
source of current knowledge. Clearly much work lies ahead ately apparent: first, we have a long path ahead to translate
of us to fully understand the causes, biological mechanisms genetic discoveries into identifiable mechanisms of disease
and treatments of ocular and vision diseases. This book, and pathophysiology that will support rationally designed
Ocular Disease: Mechanisms and Management, provides a sub- therapeutic interventions. Second, although our field of eye
stantial starting point to launch insightful studies that will disease research is amazingly rich in mouse models that
move our field even closer to rational therapeutics. generally mimic the human condition with good fidelity
One of the drivers of this new understanding of disease across a variety of ocular conditions, the fullest understand-
comes from the vigorous work of the vision research com- ing of human disease mechanisms ultimately will require
munity over the past two decades, which has led to identify- that we turn our attention directly to careful and detailed
ing more than 500 genes that cause Mendelian ocular analysis of disease in human patients, as is considered in this
diseases. These genes encompass a wide assortment of condi- textbook.
tions that clinicians diagnose and treat, and no tissues are The future for treating diseases of the eye and visual
spared. We have identified genes that cause retinal and system will require novel insight into disease biology. But
macular degenerations, glaucoma, uveitis, cataract and already we can see major areas of opportunity to employ a
corneal dystrophies, optic neuropathies, and amblyopia, new range of therapeutic interventions, from gene therapy
strabismus and ocular motility disorders. to stem cells for regenerative medicine. This new book is the
Disease gene discovery recently advanced into the previ- medical companion to the basic textbook Adler’s Physiology
ously intractable realm of the more common and wide- of the Eye. This companion volume by Levin and Albert
spread conditions that have genetically complex etiology. In tackles the translation of basic knowledge into the realm of
2005 several groups independently identified the first gene medical understanding and practice and thereby highlights
that conveys substantial risk for developing age-related that the best of basic and clinical knowledge increasingly
macular degeneration, the complement factor H gene. have an interdependent existence and future.
Shortly thereafter several additional AMD risk genes were
identified in the immune pathways, including complement Paul A. Sieving MD, PhD
modulatory factors, using the new and powerful techniques Director, National Eye Institute, NIH
of haplotype mapping and genome-wide association studies. Bethesda, MD
This new basic knowledge forced our attention toward the September 2009
immune cascade as harboring mechanisms that culminate
in vision loss from macular degeneration in as many as one
in seven of the elderly.
Preface
The eye is a microcosm for the world of disease. Its synonym, Ophthalmology. Similar goals to those enunciated above were
“the globe,” has profound implications because, in addition followed in soliciting chapters from internationally recog-
to the geometric meaning, within its tablespoon of contents nized experts in specific areas of ophthalmic pathophysiol-
there is a world of physiology and pathophysiology. Autoim- ogy, targeted to readers of the Archives who had curiosity
mune diseases, neoplasms, infections, neurodegenerations, about current advances in diagnosing and treating eye
infarcts: these all occur within the eye and the eye’s transit disease. The concept – focused reviews by working scientists
stations within the central nervous system. Almost all of the describing up-to-date research in a clinically relevant area
same pathophysiological principles that apply to the eye – has been carried through to “Ocular Disease: Mechanisms
apply equally to the body. and Management.” The world of disease is covered from
This book is a guide to the world of ocular disease. Each pole to pole, and the book is organized by “continent”, i.e.
chapter is written by scientists who carry out exciting research area of disease. A short publication cycle has been used so
in the corresponding field. Like tour guides who are native that the information contained within is as current today as
to a region or country, these experienced authors can help is possible with contemporary publishing technology. Criti-
the reader travel through a scientific landscape, pointing out cal references are at the end of each chapter, and more
new features of familiar territory and blazing trails through extensive references are available online.
areas of wilderness. We believe this familiarity with the We hope that this book will be as instructive for the
mechanics of the disease lend each chapter an immediacy readership as it has been for its editors and the authors in
and relevance that will inform the reader for and serve as a its planning and writing. Its successful production would not
map or GPS for his or her subsequent visits. The chapters have been possible without the contributions of Laura Cruz,
themselves are deliberately succinct, a Baedeker somewhere who did the administrative organizing for the authors, and
between a gazetteer and a comprehensive travelogue, but the helpful involvement of the publisher, particularly Russell
with all the critical details that make understanding of a Gabbedy and Ben Davie.
specific pathological mechanism possible.
This book arose from a long-running a series named LAL
“Mechanisms of Ophthalmic Disease” in the Archives of DMA